FedEx Prepares For COVID-19 Vaccine Volume Growth, Begins Shipping Newly Approved Vaccine
FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the worlds largest express transportation company, announced today that it has begun shipping the newly approved COVID-19 vaccine on behalf of McKesson Corp. to dosing centers throughout the United States.
- FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the worlds largest express transportation company, announced today that it has begun shipping the newly approved COVID-19 vaccine on behalf of McKesson Corp. to dosing centers throughout the United States.
- As vaccine production ramps up and more vaccines are approved, we expect to see a significant uptick in COVID-19 vaccine and supply kit volume moving through our network, said Don Colleran, president and CEO for FedEx Express.
- FedEx SenseAware ID, a Bluetooth low-energy sensor device, is affixed to vaccine shipments, helping to ensure these temperature-sensitive deliveries move swiftly and safely through the FedEx Express U.S. network with FedEx Priority Overnight service.
- To learn more about how FedEx connects people and possibilities around the world, please visit about.fedex.com .